Dominique Modrowski

Author PubWeight™ 8.75^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	ErbB3 silencing reduces osteosarcoma cell proliferation and tumor growth in vivo.	Gene	2013	1.38
2	Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.	Cancer Res	2007	0.91
3	High Wnt signaling represses the proapoptotic proteoglycan syndecan-2 in osteosarcoma cells.	Cancer Res	2010	0.86
4	Calpain-6 is an endothelin-1 signaling dependent protective factor in chemoresistant osteosarcoma.	Int J Cancer	2011	0.83
5	Cadherin-mediated cell-cell adhesion and signaling in the skeleton.	Calcif Tissue Int	2013	0.82
6	Growth factors and bone formation in osteoporosis: roles for fibroblast growth factor and transforming growth factor beta.	Curr Pharm Des	2004	0.82
7	Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice.	J Bone Miner Res	2012	0.82
8	Dual involvement of protein kinase C delta in apoptosis induced by syndecan-2 in osteoblasts.	J Cell Biochem	2006	0.82
9	Apoptosis in membranous bone formation: role of fibroblast growth factor and bone morphogenetic protein signaling.	Crit Rev Eukaryot Gene Expr	2005	0.79
10	Targeting the E3 ubiquitin casitas B-lineage lymphoma decreases osteosarcoma cell growth and survival and reduces tumorigenesis.	J Bone Miner Res	2012	0.76